| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 42.93B | 40.73B | 37.79B | 45.16B | 36.94B | 23.52B |
| Gross Profit | 12.96B | 12.36B | 6.18B | 30.07B | 22.84B | 13.05B |
| EBITDA | 4.45B | 3.60B | 1.19B | 11.57B | 10.33B | 4.26B |
| Net Income | 1.50M | -651.20M | -2.37B | 4.10B | 5.60B | 1.66B |
Balance Sheet | ||||||
| Total Assets | 82.09B | 83.43B | 80.23B | 83.35B | 79.77B | 71.54B |
| Cash, Cash Equivalents and Short-Term Investments | 3.91B | 1.53B | 1.79B | 5.02B | 3.20B | 4.07B |
| Total Debt | 6.37B | 5.61B | 5.44B | 5.97B | 5.94B | 4.98B |
| Total Liabilities | 26.39B | 23.17B | 19.48B | 21.96B | 20.78B | 17.80B |
| Stockholders Equity | 55.70B | 60.26B | 60.76B | 61.39B | 58.99B | 53.75B |
Cash Flow | ||||||
| Free Cash Flow | 1.61B | 557.40M | -1.65B | 2.77B | -1.74B | -3.73B |
| Operating Cash Flow | 2.98B | 3.81B | 666.16M | 9.60B | 7.35B | 4.21B |
| Investing Cash Flow | -1.18B | -2.64B | -900.00M | -6.61B | -8.05B | -3.32B |
| Financing Cash Flow | -559.70M | -1.45B | -2.77B | -1.40B | 117.44M | 2.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ₹60.64B | 12.10 | ― | 3.68% | -7.53% | 42.74% | |
66 Neutral | ₹41.38B | 12.54 | ― | 2.10% | -5.14% | 7.25% | |
65 Neutral | ₹57.28B | 23.54 | ― | 0.47% | 5.61% | 33.63% | |
64 Neutral | ₹114.90B | 28.71 | ― | 0.80% | 21.68% | 45.18% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | ₹30.44B | -46.40 | ― | 3.11% | 10.35% | ― | |
49 Neutral | ₹38.16B | 115.03 | ― | 1.60% | 3.30% | 91.30% |
Gujarat Alkalies and Chemicals Ltd. has announced that it will participate in an investor and analyst meeting organized by Antique Stock Broking Ltd. in Mumbai on March 23, 2026, to be held in person through both group and one-on-one interactions. During this engagement, the company plans to share only its existing corporate and earnings presentations and other information already available in the public domain, underscoring a focus on transparent communication with shareholders and institutional stakeholders without disclosing any new unpublished data.
The scheduled investor meet reflects the company’s ongoing efforts to maintain active dialogue with the investment community and enhance visibility in capital markets. Such interactions can help investors better understand Gujarat Alkalies and Chemicals’ business performance and strategy, potentially supporting market confidence and more informed valuation of the stock.
Gujarat Alkalies and Chemicals Ltd has published in leading national and regional newspapers the extracts of its standalone and consolidated unaudited financial results for the third quarter and nine months ended 31 December 2025, in line with SEBI’s disclosure norms. The results, which have undergone a limited review by statutory auditors and were approved by the board on 6 February 2026, reflect an accounting correction in the valuation of spent palladium catalyst inventory that significantly increased its carrying value and profits for the period, while the company also noted that the impact of India’s new labour codes on its employee benefit liabilities is currently assessed as immaterial, with ongoing monitoring for future implications.
Gujarat Alkalies and Chemicals Limited has appointed Maulik Gandhi as General Manager (IT & Digital Transformation) effective 2 January 2026, strengthening its senior management team in line with regulatory disclosure requirements. Gandhi, a computer science engineer with a management degree from IIM Ahmedabad and over 25 years of experience in enterprise IT and business transformation across areas such as B2B IT, sales planning, sustainability and energy management, is expected to spearhead the company’s digital and business transformation initiatives, supporting operational efficiency and reinforcing its strategic push toward technology-led, green-focused growth.
Gujarat Alkalies & Chemicals Ltd. has notified the stock exchanges that its trading window for dealing in the company’s equity shares will be closed for all designated persons from 1 January 2026, in line with SEBI’s Prohibition of Insider Trading Regulations, 2015. The window will reopen 48 hours after the company announces its unaudited financial results for the quarter ending 31 December 2025, underscoring the company’s adherence to insider trading norms and signaling that third-quarter financial disclosures are forthcoming, a key point of attention for investors and other market participants.